Document Type

Article

Publication Date

May 2022

Patent Number

11337931

CPC

A61K 9/5123, A61K 9/5169, A61K 31/436, A61K 31/5377, A61K 31/573, A61K 31/675, A61K 47/62, A61K 47/6925, A61K 9/513, A61P 9/00, C07K 7/06

Abstract

A targeting nanoparticle composition and method of treatment for diseases associated with major basement membrane components of blood vessels accessible from blood stream is presented. The composition includes pegylated perfluorocarbon nanoparticles having a targeting ligand attached that targets the basement membrane components, specifically collagen IV. The targeted nanoparticles may contain at least one pharmaceutically active agent capable of treating a glomerular disease such as lupus nephritis.

Application Number

16/950327

Assignees

University of South Florida

Filing Date

11/17/2020

Share

COinS